The OncoAlert Weekly RoundUp September 12-18, 2025: PRIME | NECTIN-4 | PREOPANC-2 | WU-KONG1B & More

19/09/2025 5 min
The OncoAlert Weekly RoundUp September 12-18, 2025: PRIME | NECTIN-4 | PREOPANC-2 | WU-KONG1B & More

Listen "The OncoAlert Weekly RoundUp September 12-18, 2025: PRIME | NECTIN-4 | PREOPANC-2 | WU-KONG1B & More"

Episode Synopsis

The OncoAlert Weekly Roundup is your go-to podcast for the latest, most impactful updates in oncology from across the globe 🌍. Each week, we break down the key studies shaping cancer care—so you stay ahead, in just minutes.This week’s highlights include:🔹 PRIME Diagnostic Trial: Bi-MRI vs. mp-MRI in #ProstateCancer🔹 NECTIN4-CAR T cells show promise in #BladderCancer🔹 Global consensus on bladder-sparing MIBC trial endpoints🔹 PREOPANC-2 in resectable #PancreaticCancer🔹 WU-KONG1B: Sunvozertinib in EGFR exon20 #NSCLC🔹 Updated ASTRO–ASCO–SSO guideline on PMRT in #BreastCancer🔹 Impact of sequential ADCs in HER2- MBC🔹 Sacituzumab govitecan in low-grade serous #OvarianCancer🔹 OlAnCa Trial: Olanzapine in cancer cachexia🔹 Nurse-delivered Meaning-Centered Psychotherapy for advanced cancer👉 Don’t miss an episode—subscribe now for concise, evidence-based insights that matter to your practice.✨ Stay tuned. Stay informed. Stay #OncoAlert.